- Release Date: 06/04/20 09:09
- Summary: FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients
- Price Sensitive: Yes
- Download Document 89.95KB
Ann: FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients
- There are more pages in this discussion • 311 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.060(5.53%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.20 | $1.11 | $11.93M | 10.23M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 19263 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 27388 | 9 |
View Market Depth
| Last trade - 12.37pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.16 |
Change
0.060 ( 7.01 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.20 | $1.12 | 2417983 | ||
| Last updated 12.57pm 06/05/2024 ? | |||||
| MSB (ASX) Chart |